"This is the first time that a treatment for AD is being studied using the amyloid imaging compound where an effect has been measured," said Prof. Dr. Agneta Nordberg, MD, PhD of the Karolinska Institute, "The results to date are promising and we look forward to the further analyses of the scans and spinal fluid and at the end of 6 months of treatment."
posted
Dusty, you still in this? I may jump back ing.
Axonyx to Present at the Wall Street Analyst Forum Thursday February 23, 8:33 am ET Presentation to be Web Cast Live on Corporate Web Site
NEW YORK--(BUSINESS WIRE)--Feb. 23, 2006--Axonyx Inc. (NASDAQ: AXYX - News), today announced that Gosse Bruinsma, MD, President and CEO of Axonyx, will be presenting at the Wall Street Analyst Forum, which will take place at the Princeton Club, New York, NY. Dr. Bruinsma is expected to discuss the Company's clinical development program, strategic initiatives and market opportunities. The Axonyx presentation is scheduled for 8:20 am Eastern Time on Wednesday, March 1, 2006.
-------------------- Stick with Repo's plan in '07 - FRPT/DKAM!
IP: Logged |